R2129 Antimicrobial resistance of clinical isolates Acinetobacter baumannii in a university hospital

Antimicrobial drug resistance against the background of the COVID-19 pandemic in Bulgaria and Europe: A profound review of the available literature sources

“…Infections caused by such bacteria are treated longer, with a combination of several antibiotics, often these patients are subject to hospitalization. AMR complicates the treatment of infections and increases the risk of spreading the disease, greater severity of disease, and death [11,14]. Also, many chronic infections are due to bacterial biofilms.…”

“…The antibiotic binds to structures only in the bacterial cell that is unique and unparalleled in human and animal cells, so they are effective and relatively low toxic. There are 61 authorized types of antibiotics in Bulgaria, which are sold under 197 trade names and 375 dosage forms [10,11].…”

“…In Bulgaria, the use of antibiotics increased to 22.7 DDD per 1000 people per day in the hospital system, and in outpatient care, the daily consumption was 20.0 DDD per 1000 people. The use of antibiotics in our country has increased significantly in recent years associated with the COVID-19 pandemic [10,11]. At its lowest levels of use, it was 17.00 per 1000 people per day.…”